List of Tables
Table 1. Global Pharmerging Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tier 1
Table 3. Key Players of Tier 2
Table 4. Key Players of Tier 3
Table 5. Global Pharmerging Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Pharmerging Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Pharmerging Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Pharmerging Market Share by Region (2017-2022)
Table 9. Global Pharmerging Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Pharmerging Market Share by Region (2023-2028)
Table 11. Pharmerging Market Trends
Table 12. Pharmerging Market Drivers
Table 13. Pharmerging Market Challenges
Table 14. Pharmerging Market Restraints
Table 15. Global Pharmerging Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Pharmerging Revenue Share by Players (2017-2022)
Table 17. Global Top Pharmerging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmerging as of 2021)
Table 18. Ranking of Global Top Pharmerging Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Pharmerging Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmerging Product Solution and Service
Table 22. Date of Enter into Pharmerging Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmerging Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Pharmerging Revenue Market Share by Type (2017-2022)
Table 26. Global Pharmerging Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Pharmerging Revenue Market Share by Type (2023-2028)
Table 28. Global Pharmerging Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Pharmerging Revenue Share by Application (2017-2022)
Table 30. Global Pharmerging Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Pharmerging Revenue Share by Application (2023-2028)
Table 32. North America Pharmerging Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Pharmerging Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Pharmerging Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Pharmerging Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Pharmerging Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Pharmerging Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Pharmerging Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Pharmerging Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Pharmerging Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Pharmerging Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Pharmerging Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Pharmerging Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Pharmerging Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Pharmerging Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Pharmerging Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Pharmerging Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Pharmerging Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Pharmerging Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Pharmerging Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Pharmerging Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Pharmerging Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Pharmerging Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Pharmerging Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Pharmerging Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Pharmerging Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Pharmerging Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pharmerging Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pharmerging Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Pharmerging Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Pharmerging Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Pharmerging Product
Table 65. Pfizer Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Pharmerging Product
Table 70. Sanofi Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 71. Sanofi Recent Developments
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Pharmerging Product
Table 75. GlaxoSmithKline Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 76. GlaxoSmithKline Recent Developments
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Pharmerging Product
Table 80. AstraZeneca Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 81. AstraZeneca Recent Developments
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Pharmerging Product
Table 85. Novartis Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 86. Novartis Recent Developments
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Pharmerging Product
Table 90. Johnson & Johnson Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 91. Johnson & Johnson Recent Developments
Table 92. F. Hoffmann-La Roche Company Details
Table 93. F. Hoffmann-La Roche Business Overview
Table 94. F. Hoffmann-La Roche Pharmerging Product
Table 95. F. Hoffmann-La Roche Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 96. F. Hoffmann-La Roche Recent Developments
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Pharmerging Product
Table 100. Eli Lilly Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 101. Eli Lilly Recent Developments
Table 102. Boehringer Ingelheim Company Details
Table 103. Boehringer Ingelheim Business Overview
Table 104. Boehringer Ingelheim Pharmerging Product
Table 105. Boehringer Ingelheim Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 106. Boehringer Ingelheim Recent Developments
Table 107. Novo Nordisk Company Details
Table 108. Novo Nordisk Business Overview
Table 109. Novo Nordisk Pharmerging Product
Table 110. Novo Nordisk Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 111. Novo Nordisk Recent Developments
Table 112. AbbVie Company Details
Table 113. AbbVie Business Overview
Table 114. AbbVie Pharmerging Product
Table 115. AbbVie Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 116. AbbVie Recent Developments
Table 117. Sun Pharmaceutical Company Details
Table 118. Sun Pharmaceutical Business Overview
Table 119. Sun Pharmaceutical Pharmerging Product
Table 120. Sun Pharmaceutical Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 121. Sun Pharmaceutical Recent Developments
Table 122. Teva Pharmaceutical Industries Company Details
Table 123. Teva Pharmaceutical Industries Business Overview
Table 124. Teva Pharmaceutical Industries Pharmerging Product
Table 125. Teva Pharmaceutical Industries Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 126. Teva Pharmaceutical Industries Recent Developments
Table 127. Mitsubishi Tanabe Pharma Company Details
Table 128. Mitsubishi Tanabe Pharma Business Overview
Table 129. Mitsubishi Tanabe Pharma Pharmerging Product
Table 130. Mitsubishi Tanabe Pharma Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 131. Mitsubishi Tanabe Pharma Recent Developments
Table 132. Bristol-Myers Squibb Company Details
Table 133. Bristol-Myers Squibb Business Overview
Table 134. Bristol-Myers Squibb Pharmerging Product
Table 135. Bristol-Myers Squibb Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 136. Bristol-Myers Squibb Recent Developments
Table 137. Kyowa Hakko Kirin Company Details
Table 138. Kyowa Hakko Kirin Business Overview
Table 139. Kyowa Hakko Kirin Pharmerging Product
Table 140. Kyowa Hakko Kirin Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 141. Kyowa Hakko Kirin Recent Developments
Table 142. CSL Behring Company Details
Table 143. CSL Behring Business Overview
Table 144. CSL Behring Pharmerging Product
Table 145. CSL Behring Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 146. CSL Behring Recent Developments
Table 147. Takeda Company Details
Table 148. Takeda Business Overview
Table 149. Takeda Pharmerging Product
Table 150. Takeda Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 151. Takeda Recent Developments
Table 152. Amgen Company Details
Table 153. Amgen Business Overview
Table 154. Amgen Pharmerging Product
Table 155. Amgen Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 156. Amgen Recent Developments
Table 157. Bayer Company Details
Table 158. Bayer Business Overview
Table 159. Bayer Pharmerging Product
Table 160. Bayer Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 161. Bayer Recent Developments
Table 162. Biogen Company Details
Table 163. Biogen Business Overview
Table 164. Biogen Pharmerging Product
Table 165. Biogen Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 166. Biogen Recent Developments
Table 167. Eisai Company Details
Table 168. Eisai Business Overview
Table 169. Eisai Pharmerging Product
Table 170. Eisai Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 171. Eisai Recent Developments
Table 172. Daiichi Sankyo Company Details
Table 173. Daiichi Sankyo Business Overview
Table 174. Daiichi Sankyo Pharmerging Product
Table 175. Daiichi Sankyo Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 176. Daiichi Sankyo Recent Developments
Table 177. Dainippon Sumitomo Pharma Company Details
Table 178. Dainippon Sumitomo Pharma Business Overview
Table 179. Dainippon Sumitomo Pharma Pharmerging Product
Table 180. Dainippon Sumitomo Pharma Revenue in Pharmerging Business (2017-2022) & (US$ Million)
Table 181. Dainippon Sumitomo Pharma Recent Developments
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmerging Market Share by Type: 2021 VS 2028
Figure 2. Tier 1 Features
Figure 3. Tier 2 Features
Figure 4. Tier 3 Features
Figure 5. Global Pharmerging Market Share by Application: 2021 VS 2028
Figure 6. Lung Cancer Case Studies
Figure 7. Breast Cancer Case Studies
Figure 8. Chronic Myeloid Leukemia Case Studies
Figure 9. Lymphomas Case Studies
Figure 10. Other Case Studies
Figure 11. Pharmerging Report Years Considered
Figure 12. Global Pharmerging Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Pharmerging Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Pharmerging Market Share by Region: 2021 VS 2028
Figure 15. Global Pharmerging Market Share by Players in 2021
Figure 16. Global Top Pharmerging Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmerging as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Pharmerging Revenue in 2021
Figure 18. North America Pharmerging Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Pharmerging Market Size Market Share by Type (2017-2028)
Figure 20. North America Pharmerging Market Size Market Share by Application (2017-2028)
Figure 21. North America Pharmerging Market Size Share by Country (2017-2028)
Figure 22. United States Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Pharmerging Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Pharmerging Market Size Market Share by Type (2017-2028)
Figure 26. Europe Pharmerging Market Size Market Share by Application (2017-2028)
Figure 27. Europe Pharmerging Market Size Share by Country (2017-2028)
Figure 28. Germany Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Pharmerging Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Pharmerging Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Pharmerging Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Pharmerging Market Size Share by Region (2017-2028)
Figure 38. China Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Pharmerging Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Pharmerging Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Pharmerging Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Pharmerging Market Size Share by Country (2017-2028)
Figure 48. Mexico Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Pharmerging Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Pharmerging Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Pharmerging Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Pharmerging Market Size Share by Country (2017-2028)
Figure 54. Turkey Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 60. AstraZeneca Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 62. Johnson & Johnson Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 64. Eli Lilly Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 65. Boehringer Ingelheim Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 66. Novo Nordisk Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 67. AbbVie Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 68. Sun Pharmaceutical Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 69. Teva Pharmaceutical Industries Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 70. Mitsubishi Tanabe Pharma Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 72. Kyowa Hakko Kirin Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 73. CSL Behring Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 74. Takeda Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 75. Amgen Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 76. Bayer Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 77. Biogen Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 78. Eisai Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 79. Daiichi Sankyo Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 80. Dainippon Sumitomo Pharma Revenue Growth Rate in Pharmerging Business (2017-2022)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed